N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-L-threo-sphingosine
|
K025080-50ug
|
99% |
474943-08-3 |
50ug
|
¥ 1390.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-L-threo-sphingosine
|
K025080-250ug
|
99% |
474943-08-3 |
250ug
|
¥ 4804.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025079-50ug
|
99% |
474943-06-1 |
50ug
|
¥ 4088.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025079-250ug
|
99% |
474943-06-1 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025079-100ug
|
99% |
474943-06-1 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphinganine
|
K025078-100ug
|
99% |
474943-05-0 |
100ug
|
¥ 2249.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphinganine
|
K025078-50ug
|
99% |
474943-05-0 |
50ug
|
¥ 1390.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphinganine
|
K025078-250ug
|
99% |
474943-05-0 |
250ug
|
¥ 4804.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-50ug
|
99% |
474943-04-9 |
50ug
|
¥ 4088.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-250ug
|
99% |
474943-04-9 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-100ug
|
99% |
474943-04-9 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-100ug
|
99% |
474943-01-6 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-50ug
|
99% |
474943-01-6 |
50ug
|
¥ 4088.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-250ug
|
99% |
474943-01-6 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025075-50ug
|
99% |
474942-98-8 |
50ug
|
¥ 4088.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025075-250ug
|
99% |
474942-98-8 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025075-100ug
|
99% |
474942-98-8 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-棕榈酰同型半胱氨酸(铵盐)
|
K025072-100mg
|
99% |
474942-73-9 |
100mg
|
¥ 14140.0
|
4~8周 |
科威 |
N-棕榈酰同型半胱氨酸(铵盐)
|
K025072-25mg
|
99% |
474942-73-9 |
25mg
|
¥ 4040.0
|
4~8周 |
科威 |
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-500mg
|
99% |
474923-51-8 |
500mg
|
¥ 11243.0
|
4~8周 |
科威 |
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-25mg
|
99% |
474923-51-8 |
25mg
|
¥ 1880.0
|
4~8周 |
科威 |
1,2-Dioleoyl-sn-Glycero-3-Phospho(Ethylene Glycol) (Sodium Salt)
|
K025071-100mg
|
99% |
474923-51-8 |
100mg
|
¥ 5110.0
|
4~8周 |
科威 |
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt)
|
K025070-100mg
|
99% |
474923-49-4 |
100mg
|
¥ 5519.0
|
4~8周 |
科威 |
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt)
|
K025070-500mg
|
99% |
474923-49-4 |
500mg
|
¥ 17784.0
|
4~8周 |
科威 |